{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T12:47:06Z","timestamp":1772196426366,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1002\/jps.20484","type":"journal-article","created":{"date-parts":[[2005,11,28]],"date-time":"2005-11-28T21:18:24Z","timestamp":1133212704000},"page":"80-96","source":"Crossref","is-referenced-by-count":77,"title":["Anthrax vaccine powder formulations for nasal mucosal delivery"],"prefix":"10.1016","volume":"95","author":[{"given":"Ge","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sangeeta B.","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura J.","family":"Peek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duane T.","family":"Brandau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew S.","family":"Ferriter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy D.","family":"Woodley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brandi M.","family":"Ford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin D.","family":"Mar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A.","family":"Mikszta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.Robin","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Ulrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noel G.","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.Russell","family":"Middaugh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent J.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1002\/jps.20484_bb0010","first-page":"RA276","article-title":"Anthrax\u2014An overview","volume":"9","author":"Oncu","year":"2003","journal-title":"Med Sci Monit"},{"key":"10.1002\/jps.20484_bb0015","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1128\/IAI.70.4.2022-2028.2002","article-title":"Mucosal or parenteral administration of microsphere-associated Bacillus anthracis protective antigen protects against anthrax infection in mice","volume":"70","author":"Flick-Smith","year":"2002","journal-title":"Infect Immun"},{"key":"10.1002\/jps.20484_bb0020","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1006\/bbrc.2001.5018","article-title":"Effect of pH on stability of anthrax lethal factor: Correlation between denaturation and activity","volume":"284","author":"Gupta","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1002\/jps.20484_bb0025","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/20014091096738","article-title":"Anthrax toxin","volume":"27","author":"Bhatnagar","year":"2001","journal-title":"Crit Rev Microbiol"},{"key":"10.1002\/jps.20484_bb0030","series-title":"Topley and Wilson's microbiology and microbial infections","article-title":"Anthrax","author":"Quinn","year":"1998"},{"key":"10.1002\/jps.20484_bb0035","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1089\/104303403322542310","article-title":"Protective immunity evoked against anthrax lethal toxin after a single intramuscular administration of an adenovirus-based vaccine encoding humanized protective antigen","volume":"14","author":"Tan","year":"2003","journal-title":"Hum Gene Ther"},{"key":"10.1002\/jps.20484_bb0040","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1083\/jcb.200312072","article-title":"Membrane insertion of anthrax protective antigen and cytoplasmic delivery of lethal factor occur at different stages of the endocytic pathway","volume":"166","author":"Abrami","year":"2004","journal-title":"J Cell Biol"},{"key":"10.1002\/jps.20484_bb0045","doi-asserted-by":"crossref","first-page":"15542","DOI":"10.1016\/S0021-9258(19)49569-0","article-title":"Fusions of anthrax toxin lethal factor to the ADP-ribosylation domain of Pseudomonas exotoxin A are potent cytotoxins which are translocated to the cytosol of mammalian cells","volume":"267","author":"Arora","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1002\/jps.20484_bb0050","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1128\/IAI.70.8.4477-4484.2002","article-title":"Identification of amino acid residues of anthrax protective antigen involved in binding with lethal factor","volume":"70","author":"Chauhan","year":"2002","journal-title":"Infect Immun"},{"key":"10.1002\/jps.20484_bb0055","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1128\/IAI.59.10.3472-3477.1991","article-title":"Contribution of individual toxin components to virulence of Bacillus anthracis","volume":"59","author":"Pezard","year":"1991","journal-title":"Infect Immun"},{"key":"10.1002\/jps.20484_bb0060","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1046\/j.1365-2672.1999.00891.x","article-title":"Lethal toxin actions and their consequences","volume":"87","author":"Hanna","year":"1999","journal-title":"J Appl Microbiol"},{"key":"10.1002\/jps.20484_bb0065","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1073\/pnas.79.10.3162","article-title":"Anthrax toxin edema factor: A bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells","volume":"79","author":"Leppla","year":"1982","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/jps.20484_bb0070","doi-asserted-by":"crossref","first-page":"4432","DOI":"10.1128\/IAI.62.10.4432-4439.1994","article-title":"Anthrax edema toxin differentially regulates lipopolysaccharide-induced monocyte production of tumor necrosis factor alpha and interleukin-6 by increasing intracellular cyclic AMP","volume":"62","author":"Hoover","year":"1994","journal-title":"Infect Immun"},{"key":"10.1002\/jps.20484_bb0075","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev.cellbio.19.111301.140655","article-title":"Anthrax toxin","volume":"19","author":"Collier","year":"2003","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10.1002\/jps.20484_bb0080","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1021\/bi015860m","article-title":"Stoichiometry of anthrax toxin complexes","volume":"41","author":"Mogridge","year":"2002","journal-title":"Biochemistry"},{"key":"10.1002\/jps.20484_bb0085","first-page":"279","article-title":"Immunogenic effect of anthrax protective antigen","volume":"26","author":"Prokupek","year":"1981","journal-title":"Vet Med (Praha)"},{"key":"10.1002\/jps.20484_bb0090","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/0264-410X(94)90027-2","article-title":"Efficacy of a standard human anthrax vaccine against Bacillus anthracis spore challenge in guinea-pigs","volume":"12","author":"Ivins","year":"1994","journal-title":"Vaccine"},{"key":"10.1002\/jps.20484_bb0095","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1016\/S0264-410X(03)00109-9","article-title":"Evaluation of the compatibility of a second generation recombinant anthrax vaccine with aluminum-containing adjuvants","volume":"21","author":"Jendrek","year":"2003","journal-title":"Vaccine"},{"key":"10.1002\/jps.20484_bb0100","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0928-8244(03)00085-3","article-title":"Characterisation of the immune response to the UK human anthrax vaccine","volume":"36","author":"Baillie","year":"2003","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1002\/jps.20484_bb0105","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1128\/IAI.69.5.2888-2893.2001","article-title":"Search for correlates of protective immunity conferred by anthrax vaccine","volume":"69","author":"Reuveny","year":"2001","journal-title":"Infect Immun"},{"key":"10.1002\/jps.20484_bb0110","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1128\/IAI.54.2.537-542.1986","article-title":"Cloning and expression of the Bacillus anthracis protective antigen gene in Bacillus subtilis","volume":"54","author":"Ivins","year":"1986","journal-title":"Infect Immun"},{"key":"10.1002\/jps.20484_bb0115","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1128\/IAI.66.7.3447-3448.1998","article-title":"Study of immunization against anthrax with the purified recombinant protective antigen of Bacillus anthracis","volume":"66","author":"Singh","year":"1998","journal-title":"Infect Immun"},{"key":"10.1002\/jps.20484_bb0120","unstructured":"Clinicaltrials.gov website www.clinicaltrials.gov\/ct\/show\/NCT00057525. ed."},{"key":"10.1002\/jps.20484_bb0125","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1016\/S0264-410X(00)00058-X","article-title":"Effective mucosal immunization against respiratory syncytial virus using purified F protein and a genetically detoxified cholera holotoxin, CT-E29H","volume":"18","author":"Tebbey","year":"2000","journal-title":"Vaccine"},{"key":"10.1002\/jps.20484_bb0130","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1089\/vim.1999.12.107","article-title":"Antigen-specific cytokine and antibody isotype profiles induced by mucosal and systemic immunization with recombinant adenoviruses","volume":"12","author":"Papp","year":"1999","journal-title":"Viral Immunol"},{"key":"10.1002\/jps.20484_bb0135","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0264-410X(02)00516-9","article-title":"Mucosal and systemic antibody responses against an acellular pertussis vaccine in mice after intranasal co-administration with recombinant cholera toxin B subunit as an adjuvant","volume":"21","author":"Isaka","year":"2003","journal-title":"Vaccine"},{"key":"10.1002\/jps.20484_bb0140","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1086\/426865","article-title":"Protective immunization against inhalational anthrax: A comparison of minimally-invasive delivery platforms","volume":"191","author":"Mikszta","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1002\/jps.20484_bb0145","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1002\/jps.10439","article-title":"Derivative absorbance spectroscopy and protein phase diagrams as tools for comprehensive protein characterization: A bGCSF case study","volume":"92","author":"Kueltzo","year":"2003","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.20484_bb0150","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1586\/14760584.2.2.305","article-title":"CpG DNA as a vaccine adjuvant","volume":"2","author":"Klinman","year":"2003","journal-title":"Expert Review of Vaccines"},{"key":"10.1002\/jps.20484_bb0155","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1002\/jps.10440","article-title":"Structural characterization of bovine granulocyte colony stimulating factor: Effect of temperature and pH","volume":"92","author":"Kueltzo","year":"2003","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.20484_bb0160","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.vaccine.2004.06.049","article-title":"SVJ 2004. A novel dry powder influenza vaccine and intranasal delivery technology: Induction of systemic and mucosal immune responses in rats","volume":"23","author":"Huang","year":"2004","journal-title":"Vaccine"},{"key":"10.1002\/jps.20484_bb0165","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0168-1656(96)01569-6","article-title":"Thermostabilization of protective antigen\u2014The binding component of anthrax lethal toxin","volume":"50","author":"Radha","year":"1996","journal-title":"J Biotechnol"},{"key":"10.1002\/jps.20484_bb0170","doi-asserted-by":"crossref","first-page":"6922","DOI":"10.1021\/bi00242a016","article-title":"Alternatively folded states of an immunoglobulin","volume":"30","author":"Buchner","year":"1991","journal-title":"Biochemistry"},{"key":"10.1002\/jps.20484_bb0175","doi-asserted-by":"crossref","first-page":"12255","DOI":"10.1021\/bi00163a040","article-title":"Molten globule monomer to condensed dimer: Role of disulfide bonds in platelet factor-4 folding and subunit association","volume":"31","author":"Mayo","year":"1992","journal-title":"Biochemistry"},{"key":"10.1002\/jps.20484_bb0180","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1110\/ps.0201802","article-title":"Alpha-crystallin binds to the aggregation-prone molten-globule state of alkaline protease: Implications for preventing irreversible thermal denaturation","volume":"11","author":"Tanksale","year":"2002","journal-title":"Protein Sci"},{"key":"10.1002\/jps.20484_bb0185","doi-asserted-by":"crossref","first-page":"6803","DOI":"10.1021\/bi049709z","article-title":"Circumnavigating misfolding traps in the energy landscape through protein engineering: Suppression of molten globule and aggregation in carbonic anhydrase","volume":"43","author":"Karlsson","year":"2004","journal-title":"Biochemistry"},{"key":"10.1002\/jps.20484_bb0190","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ijbiomac.2004.03.006","article-title":"Comparative studies on trifluoroethanol (TFE) state of a thermophilic alpha-amylase and its mesophilic counterpart: Limited proteolysis, conformational analysis, aggregation and reactivation of the enzymes","volume":"34","author":"Asghari","year":"2004","journal-title":"Int J Biol Macromol"},{"key":"10.1002\/jps.20484_bb0195","doi-asserted-by":"crossref","first-page":"5045","DOI":"10.1021\/bi049965b","article-title":"Conformational dynamics of the GdmHCl-induced molten globule state of creatine kinase monitored by hydrogen exchange and mass spectrometry","volume":"43","author":"Mazon","year":"2004","journal-title":"Biochemistry"},{"key":"10.1002\/jps.20484_bb0200","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jmb.2004.07.024","article-title":"Unfolding a folding disease: Folding, misfolding and aggregation of the marble brain syndrome-associated mutant H107Y of human carbonic anhydrase II","volume":"342","author":"Almstedt","year":"2004","journal-title":"J Mol Biol"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916319414?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916319414?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T13:45:56Z","timestamp":1626788756000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354916319414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S0022354916319414"],"URL":"https:\/\/doi.org\/10.1002\/jps.20484","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}